- Home
- ALT vs CINT Comparison
ALT vs CINT Comparison
Compare ALT & CINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALT | CINT |
|---|---|---|
| Founded | 1997 | 1995 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 576.0M | 566.6M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ALT | CINT |
|---|---|---|
| Price | $5.32 | $4.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $16.33 | $6.96 |
| AVG Volume (30 Days) | ★ 3.5M | 142.0K |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 46.10 |
| EPS | N/A | ★ 0.27 |
| Revenue | $20,000.00 | ★ $467,906,000.00 |
| Revenue This Year | N/A | $13.14 |
| Revenue Next Year | N/A | $12.91 |
| P/E Ratio | ★ N/A | $16.73 |
| Revenue Growth | N/A | ★ 1.90 |
| 52 Week Low | $2.90 | $3.98 |
| 52 Week High | $9.59 | $8.00 |
Technical Indicators
Market Signals| Indicator | ALT | CINT |
|---|---|---|
| Relative Strength Index (RSI) | 61.41 | 49.15 |
| Support Level | $5.03 | $4.44 |
| Resistance Level | $5.83 | $4.92 |
| Average True Range (ATR) | 0.38 | 0.14 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 47.00 | 32.11 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About CINT CI&T Inc
CI&T Inc is engaged in providing plans, design, and software engineering services to enable digital transformation for companies. The company mainly develops customizable software through the implementation of several software solutions, including Machine Learning, Artificial Intelligence (AI), Analytics, Cloud, and Mobility technologies. The majority of the revenue is generated from the North America and Europe, followed by Asia, Pacific and Japan.